Tanja Zeugin

630 total citations
14 papers, 530 citations indexed

About

Tanja Zeugin is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Tanja Zeugin has authored 14 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Oncology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Tanja Zeugin's work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Tanja Zeugin is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Tanja Zeugin collaborates with scholars based in Switzerland, United States and Japan. Tanja Zeugin's co-authors include Urs Meyer, Markus H. Heim, Masaaki Kagimoto, Kim Brøsen, Thomas Zysset, Jacques Cotting, A Küpfer, Ulrich M. Zanger, Toshifumi Aoyama and Frank J. Gonzalez and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Annals of Oncology.

In The Last Decade

Tanja Zeugin

14 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tanja Zeugin Switzerland 9 338 144 143 66 62 14 530
Thomas Zysset Switzerland 16 203 0.6× 83 0.6× 133 0.9× 89 1.3× 37 0.6× 30 692
Ruby C. Chou Switzerland 17 395 1.2× 230 1.6× 224 1.6× 69 1.0× 74 1.2× 28 846
M Umeno Japan 5 340 1.0× 164 1.1× 171 1.2× 24 0.4× 19 0.3× 6 470
M. W. E. Teunissen Netherlands 11 201 0.6× 81 0.6× 99 0.7× 78 1.2× 67 1.1× 17 431
John Gorski United States 7 265 0.8× 175 1.2× 171 1.2× 38 0.6× 23 0.4× 10 646
Stellan Swedmark Sweden 14 219 0.6× 282 2.0× 98 0.7× 59 0.9× 31 0.5× 26 576
Kenji Tabata Japan 14 214 0.6× 113 0.8× 212 1.5× 90 1.4× 31 0.5× 29 561
Soraya Madani United States 6 291 0.9× 86 0.6× 153 1.1× 57 0.9× 50 0.8× 8 534
Su-Er W. Huskey United States 11 194 0.6× 133 0.9× 127 0.9× 37 0.6× 22 0.4× 13 548
H Kinoshita Japan 16 219 0.6× 124 0.9× 254 1.8× 84 1.3× 33 0.5× 51 591

Countries citing papers authored by Tanja Zeugin

Since Specialization
Citations

This map shows the geographic impact of Tanja Zeugin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Zeugin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Zeugin more than expected).

Fields of papers citing papers by Tanja Zeugin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Zeugin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Zeugin. The network helps show where Tanja Zeugin may publish in the future.

Co-authorship network of co-authors of Tanja Zeugin

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Zeugin. A scholar is included among the top collaborators of Tanja Zeugin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Zeugin. Tanja Zeugin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Huwyler, Jörg, Maria Bürgin, Tanja Zeugin, & J. Gut. (1991). Transformation of 5-hydroperoxyeicosatetraenoic acid into dihydroxy- and cysteinyl-leukotrienes by rat hepatocytes: effects of glutathione.. Molecular Pharmacology. 39(3). 314–323. 11 indexed citations
3.
Cerny, T., et al.. (1991). Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility. Journal of Cancer Research and Clinical Oncology. 117(S4). S129–S134. 5 indexed citations
4.
Brøsen, Kim, Tanja Zeugin, & Urs Meyer. (1991). Role of P450IID6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine. Clinical Pharmacology & Therapeutics. 49(6). 609–617. 97 indexed citations
5.
Zeugin, Tanja, Kim Brøsen, & Urs Meyer. (1990). Determination of imipramine and seven of its metabolites in human liver microsomes by a high-performance liquid chromatographic method. Analytical Biochemistry. 189(1). 99–102. 17 indexed citations
6.
Cerny, T., et al.. (1990). Bioavailability of subcutaneous Ifosfamide and feasibility of continuous outpatient application in cancer patients. Annals of Oncology. 1(5). 365–368. 8 indexed citations
7.
8.
Cotting, Jacques, Tanja Zeugin, U Steiger, & Jürg Reichen. (1990). Albendazole kinetics in patients with echinococcosis: Delayed absorption and impaired elimination in cholestasis. European Journal of Clinical Pharmacology. 38(6). 605–608. 25 indexed citations
9.
Frey, Felix J., Roberto F. Speck, Tanja Zeugin, et al.. (1990). Pharmacokinetics and chronic toxicity of cyclosporine A in genetic hydroxylation-deficient dark Agouti rats. Journal of Pharmacokinetics and Biopharmaceutics. 18(5). 381–399. 2 indexed citations
10.
Zeugin, Tanja, Thomas Zysset, & Jacques Cotting. (1990). Therapeutic Monitoring of Albendazole. Therapeutic Drug Monitoring. 12(2). 187–190. 34 indexed citations
11.
Matsunaga, Eiji, Tanja Zeugin, Ulrich M. Zanger, et al.. (1990). Sequence requirements for cytochrome P-450IID1 catalytic activity. A single amino acid change (Ile380 Phe) specifically decreases Vmax of the enzyme for bufuralol but not debrisoquine hydroxylation.. Journal of Biological Chemistry. 265(28). 17197–17201. 54 indexed citations
12.
Zysset, Thomas, Tanja Zeugin, & A Küpfer. (1988). In-vivo and in-vitro dextromethorphan metabolism in SD and DA rat. Biochemical Pharmacology. 37(16). 3155–3160. 42 indexed citations
13.
Küpfer, A, Tanja Zeugin, & R Preisig. (1988). Pharmacogenetic aspects of biological variability. Journal of Gastroenterology and Hepatology. 3(6). 623–633. 1 indexed citations
14.
Zysset, Thomas & Tanja Zeugin. (1986). Comparison of the Amicon Centrifree Micropartition System with the Sartorius SM 13249E Centrisart I Device to Determine Protein Free Phenytoin Concentrations. Therapeutic Drug Monitoring. 8(3). 346–351. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Zysset Breakdown of academic impact, for papers by Ruby C. Chou Breakdown of academic impact, for papers by M Umeno Breakdown of academic impact, for papers by M. W. E. Teunissen Breakdown of academic impact, for papers by John Gorski Breakdown of academic impact, for papers by Stellan Swedmark Breakdown of academic impact, for papers by Kenji Tabata Breakdown of academic impact, for papers by Soraya Madani Breakdown of academic impact, for papers by Su-Er W. Huskey Breakdown of academic impact, for papers by H Kinoshita
Rankless by CCL
2026